Related Experiment Video
Updated: May 17, 2026

06:26
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Computational tools for in silico fragment-based drug design
Jeremie Mortier1, Christin Rakers, Raphael Frederick
1Freie Universitat Berlin, Institute of Pharmacy, Department Pharmaceutical&Medicinal Chemistry, Berlin, Germany.
Current Topics in Medicinal Chemistry
|November 3, 2012
Summary
Fragment-based drug design uses small molecules to probe protein active sites. This review covers computational tools for identifying, selecting, and linking fragments into potent drug candidates.
Area of Science:
- Medicinal Chemistry
- Computational Drug Design
Background:
- Fragment-based drug design (FBDD) utilizes small molecules to explore protein binding sites.
- Fragments serve as starting points for developing potent and efficient larger drug compounds.
Purpose of the Study:
- To review computational tools supporting fragment-based drug design.
- To analyze fragment libraries, construction methods, selection strategies, and fragment linking tools.
Main Methods:
- Analysis of commercial fragment libraries.
- Review of computational methods for library construction.
- Evaluation of software for fragment selection based on predicted affinity.
- Assessment of in silico tools for fragment linkage.
Main Results:
- Commercial fragment libraries vary in size and properties.
- Various computational strategies exist for fragment library construction and selection.
- Software tools facilitate the identification of high-affinity fragments and their linkage.
Conclusions:
- Computational approaches are crucial for effective fragment-based drug design.
- The reviewed tools aid in optimizing fragment selection and lead compound development.
Related Concept Videos
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

